Clinical Trial Update: Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rabeprazole in subjects with gastroesophageal reflux disease has completed. The study was conducted under sponsorship by the University…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Rabeprazole (rabeprazole)

Snippet

Sponsor: University of Kansas | Conditions: Esophageal Reflux | Phase 2 | Status: COMPLETED